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Abstract
Background: The use of a normal database for [123I]FP-CIT SPECT imaging has been found to be helpful for cases
which are difficult to interpret by visual assessment alone, and to improve reproducibility in scan interpretation. The
aim of this study was to assess whether the use of different tomographic reconstructions affects the performance
of a normal [123I]FP-CIT SPECT database and also whether systems benefit from a system characterisation before a
database is used.
Seventy-seven [123I]FP-CIT SPECT studies from two sites and with 3-year clinical follow-up were assessed
quantitatively for scan normality using the ENC-DAT normal database obtained in well-documented healthy
subjects. Patient and normal data were reconstructed with iterative reconstruction with correction for attenuation,
scatter and septal penetration (ACSC), the same reconstruction without corrections (IRNC), and filtered back-
projection (FBP) with data quantified using small volume-of-interest (VOI) (BRASS) and large VOI (Southampton)
analysis methods. Test performance was assessed with and without system characterisation, using receiver
operating characteristics (ROC) analysis for age-independent data and using sensitivity/specificity analysis with
age-matched normal values. The clinical diagnosis at follow-up was used as the standard of truth.
Results: There were no significant differences in the age-independent quantitative assessment of scan normality
across reconstructions, system characterisation and quantitative methods (ROC AUC 0.866–0.924). With BRASS
quantification, there were no significant differences between the values of sensitivity (67.4–83.7%) or specificity
(79.4–91.2%) across all reconstruction and calibration strategies. However, the Southampton method showed
significant differences in sensitivity between ACSC (90.7%) vs IRNC (76.7%) and FBP (67.4%) reconstructions with
calibration. Sensitivity using ACSC reconstruction with this method was also significantly better with calibration than
without calibration (65.1%). Specificity using the Southampton method was unchanged across reconstruction and
calibration choices (82.4–88.2%).
Conclusions: The ability of a normal [123I]FP-CIT SPECT database to assess clinical scan normality is equivalent
across all reconstruction, system characterisation, and quantification strategies using BRASS quantification. However,
when using the Southampton quantification method, performance is sensitive to the reconstruction and calibration
strategy used.
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Background
Imaging of the dopaminergic transporter in the striatum
using [123I]FP-CIT SPECT (or 123I-ioflupane, marketed
as DaTSCAN) is a well-established technique to assist in
the diagnosis of Parkinson’s Disease (PD) [1] and Lewy
body dementia (DLB) [2]. In a substantial number of
studies, visual assessment is adequate to accurately inter-
pret images; however, with difficult to interpret cases,
quantification of striatal tracer binding can be beneficial
in coming to a more confident interpretation of the scan
[3, 4] or to increase confidence in less-experienced
readers [5].
In recent years, the Neuroimaging Committee of the
European Association of Nuclear Medicine put together
a multi-centre group to create a substantial database of
normal healthy control subjects with [123I]FP-CIT im-
aging over a wide age range [6]. The result of the project
was the ENC-DAT database of 140 subjects created
using 16 scanners, which gave both visual and quantita-
tive information on striatal dopamine transporter avail-
ability in healthy subjects between 20 and 83 years of
age. To achieve the most accurate quantitative values
possible, tomographic data was iteratively reconstructed
with corrections for photon attenuation, photon scatter
and septal penetration. Although this worked well to
help achieve the aims of the project, for wider dissemin-
ation of the database throughout the nuclear medicine
community, the use of corrections has proved to be
problematic. Attenuation correction of brain SPECT
data is frequently performed in the nuclear medicine
community using the Chang attenuation correction
method [7]. However, this method is challenging with
dopamine transporter imaging because outlining the
brain (a part of the attenuation correction process) is
difficult (low binding due to low DAT expression in
cortical areas) and often inconsistent without specialist
software [8]. Correction for scatter and septal penetra-
tion is also problematic, because the frequently used
triple energy window method [9] applied for the data-
base requires energy window definition and image pro-
cessing steps that may not be accessible to all sites.
Furthermore, in addition to these corrections, the itera-
tive reconstruction algorithm itself is also not available
or indeed preferred at some centres.
An additional challenge for disseminating the database
has been the requirement to perform a detailed phantom
calibration to define normal ranges for a specific im-
aging system [10]. This strategy was implemented be-
cause the imaging characteristics of gamma cameras are
different, even within the same scanner type. Small
changes in spatial resolution, sensitivity, and the degree
of collimator septal penetration to higher energy Iodine-
123 emissions all have an effect on the overall quality
and quantitative ability of a gamma camera system. By
performing an anthropomorphic phantom calibration of
known striatal and background activity concentrations,
it is possible to characterise the performance of individ-
ual imaging systems and derive normal ranges specific
to the gamma camera in question. Unfortunately, this
camera characterisation is not trivial and requires an
expensive anthropomorphic phantom, which has limited
its use in individual centres.
With such challenges, this paper will explore whether
the ENC-DAT database is as powerful at aiding [123I]FP-
CIT scan interpretation using iterative reconstruction
performed without corrections for attenuation and scat-
ter/septal penetration. The performance of the database
using a more widespread filtered back projection re-
construction (again without corrections) will also be
assessed. Additionally, this work will determine whether
a phantom calibration to produce a system specific nor-
mal range is required. Such assessments will be made by
comparing the diagnostic performance of quantification
with different reconstructions, with and without derived
camera specific normal ranges.
Methods
Subject data
To create the normal database, 123 subjects from the
ENC-DAT project were used in this work [6]. Data was
omitted if it was not acquired on a gamma camera with
parallel hole collimators, had no scatter energy windows
or had other technical issues. This involved data from 11
different sites and gamma cameras. To assess the diag-
nostic ability of the normal databases, 77 subjects from
two sites (London and Southampton) who had 3-year
follow-up information were used, with their working
clinical diagnosis acting as our standard of truth. Of the
77 subjects, 16 subjects were referred for an AD/DLB
differential diagnosis, 14 were referred for atypical
parkinsonian syndromes while the rest (47) were re-
ferred for helping to establish whether the patient had
Parkinson’s disease. All patients were scanned according
to the protocol defined in [6].
Data processing and analysis
Subject data were reconstructed using three different
reconstruction algorithms: the iterative reconstruction
with filtering and corrections for attenuation and septal
and scatter penetration (ACSC) recommended by the
ENC-DAT project [10]; the same iterative reconstruction
without corrections (IRNC); and uncorrected filtered
back projection (FBP). All data was filtered using a But-
terworth filter (cutoff 0.55 cm−1, power factor 10). Fol-
lowing reconstruction, image data was quantified with
Hermes BRASS [11] and Southampton [12] methods.
Using a phantom calibration technique [10], the quan-
tified ENC-DAT data was pooled in terms of “true”
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striatal/caudate/putaminal specific binding ratios (SBR).
In short, a set of phantom data from each scanner in-
volved in the ENC-DAT project was reconstructed using
each reconstruction method, so that linear relationships
of measured vs true phantom SBRs could be derived.
Using these linear relationships, normal subject data
from each scanner could be reconstructed using the
different techniques and pooled in terms of true uptake
to produce three sets of quantitative data (ACSC; IRNC;
FBP). With the data in this form, a negative linear rela-
tionship was assumed between striatal SBR and age so
that a fit could be applied together with upper and lower
bounds defined as twice the standard error of the pre-
dicted y value for each x in the regression. The lower of
these lines acted as the threshold of normality.
Using the patient’s clinical records, the working clin-
ical diagnosis of 77 subjects with 3-year follow-up acted
as the standard of truth for this study (Table 1). With
the phantom-based calibration just described, the quan-
titative SBR from the follow-up studies were converted
to true striatal SBR before being compared to the lower
limits of the normal database. This was done for each of
the three reconstruction techniques. Using the BRASS
technique, abnormality was determined using two mech-
anisms: based on whether the SBR in a single striata was
abnormal and based on whether the SBR in a single
putamen was abnormal. This is because for a given
patient, if at least one side of the brain is classified as
abnormal, then the scan is deemed to be abnormal.
Using the Southampton method, scan abnormality was
based on striatal SBRs only.
To assess whether a phantom scan is required for
scanner characterisation, a similar process as de-
scribed above was performed on non-calibrated data-
base and follow-up data. That is, the ‘raw’ SBR values
from the quantification software were used ‘as is’ and
were not converted into true SBR using the phantom
measurements.
Statistics
Diagnostic performance was assessed at two levels.
1. To determine the overall diagnostic performance of
software using different reconstruction and
calibration strategies, receiver operating
characteristics (ROC) analysis was performed to
derive the areas under the curve (AUC) and their
associated 95% confidence intervals. Significance of
differences between strategies was assessed using the
method proposed by [13].
2. Using the derived normal limits, age-stratified perform-
ance of the database was determined using sensitivity
and specificity analysis with comparisons in sensitivities
and specificities performed using a two-tailed McNe-
mar chi-square test.
In all statistical comparisons, 3-year clinical follow-up
acted as the standard of truth. Analysis was performed
using GraphPad Prism v6.0 (http://www.graphpad.com/),
with statistical significance set at p < 0.05.
Results
Overall quantitative performance
The results of ROC analysis assessing the overall diag-
nostic performance of the different reconstruction and
calibration strategies are shown in Table 2. There is no
significant difference in overall diagnostic performance
between the different reconstruction strategies, although
the highest AUC is seen with putaminal SBR using
BRASS software. There is also no difference in the per-
formance of the quantitative values from either software
when using or not using a phantom calibration.
Performance based on age-stratified normal ranges
The results from sensitivity and specificity analysis using
age-stratified normal ranges are also shown in Table 2.
Example plots showing the distribution of normal data
with ranges, and the follow-up patients are given in
Figs. 1 and 2 with the number of incorrectly classified
false positive and false negative data shown in Table 3.
Using BRASS with either striatal or putaminal SBRs,
there was no significant difference between the values of
sensitivity and specificity across all reconstruction and
calibration strategies although there were subtle dif-
ferences in false negative rates using non-calibrated
data, particularly for striatal SBR. Conversely, with the
Southampton quantification method, although specificity
remained similar across reconstructions and calibration
strategies (82.4–88.2%), there were areas with significant
changes in sensitivity. Comparisons across calibrated and
non-calibrated data showed significant (p = 0.002) im-
provements in the performance of ACSC data with cali-
bration, with sensitivity increasing from 65.1 to 90.7% and
false negative numbers changing from 14 to 4. Other
Table 1 Demographics and expected [123I]FP-CIT SPECT findings of 3-year follow-up subjects
Centre Mean age (range) Total Female/male Abnormal/normal
London 62.8 (25–84) 44 21/23 21/23
Southampton 65.9 (49–84) 33 16/17 22/11
All 63.4 (25–84) 77 37/40 (48%/52%) 43/34 (55%/45%)
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reconstructions showed slightly smaller, non-significant
changes (IRNC 67.4 to 76.7%, FBP 60.5 to 67.4%), with
false negative numbers changing from 14 to 10 (IRNC)
and 17 to 14 (FBP). Assessments across reconstruction
methods showed significantly better sensitivity in cali-
brated ACSC reconstructed data (90.7%) than both IRNC
at 76.7% and FBP at 67.4% (p = 0.03 and 0.002, respect-
ively). False negative numbers changed from 4 when using
ACSC to 10 for IRNC and 14 for FBP. No differences were
found in non-calibrated data.
Comparing analysis methods, calibrated FBP data had
significantly lower sensitivity with the Southampton
method (67.4%) with 14 false negatives compared to stri-
atal BRASS SBRs at 83.7% and 7 false negatives (p = 0.04).
With non-calibrated data, putamen BRASS SBR was sig-
nificantly more sensitive than the Southampton method
for both ACSC (83.7 and 65.1%) and FBP reconstructions
(81.4 and 60.5%) with p = 0.04 and 0.01, respectively (false
negative figures are shown in Table 3).
In Figs. 1 and 2, it is clear that some borderline cases
jump from normality to abnormality and vice-versa with
different reconstructions and calibration strategies, which
explains the differing sensitivity and specificity results.
The fact that the magnitude and age relationship of
normal values changes with the approach taken adds to
why the quantitative diagnosis changes in some studies.
These changing quantitative diagnoses, and the resulting
reconstruction- and calibration-related discordance be-
tween clinical and quantitative assessments, is sum-
marised in Fig. 3. For clinically normal subjects, there was
no clear underlying trend except for quantification derived
from calibrated FBP data being more likely to disagree
with clinical diagnosis. For clinically abnormal cases, two
patients showed an abnormal quantitative diagnosis with
the calibrated ACSC data using the Southampton SBR
method that were not quantitatively abnormal with any
other method. The Southampton method, and also to a
lesser extent the use of BRASS striatal volume-of-
interests (VOIs), displayed an improved performance
with system calibration.
Discussion
Quantification of striatal [123I]FP-CIT SPECT binding
can prove useful for clinical reporting, to assist in difficult
to interpret cases and to help less-experienced reporters
with their image interpretation. However, the normative
values from healthy subjects required to contextualise the
results are dependent on the reconstruction algorithm
and scanner used. In this study, we have explored how
different reconstructions affect the diagnostic ability of
quantitative values of striatal SBRs and also investigated
whether scanner characterisation is required to make the
best use of a multiple scanner-derived normal database.
When assessing the diagnostic performance of all SBRs
without age stratification using ROC analysis (Table 2),
there were no significant differences across each of the
investigated reconstructions. Furthermore, without age
stratification, scanner calibration to derive scanner-specific
normal ranges was also shown to have no significant bene-
fit. On closer investigation, there is a tendency for the per-
formance of putaminal SBRs with BRASS to perform
slightly better than the assessment of full striatal SBRs with
the same software, which in turn performs slightly better
than the Southampton method of quantification. Of course,
this finding depends in part on our follow-up cohort;
however, it is of no surprise with this group of patients that
putaminal SBRs would perform better than an assessment
of striatal SBRs given that idiopathic Parkinson’s disease has
a tendency to affect the putamen first. When relying on
striatal SBR measurements alone, there are instances when
reduced putaminal SBR may be dominated by a high SBR
Table 2 ROC area under the curve (AUC) data together with sensitivity and specificity performance for Southampton-specific striatal
binding ratios (SBR) and BRASS striatal and putaminal SBR
Calibrated Non-calibrated
ACSC IRNC FBP ACSC IRNC FBP
ROC (AUC) BRASS striatum 0.901 0.916 0.884 0.904 0.915 0.897
BRASS putamen 0.915 0.924 0.897 0.919 0.921 0.906
Southampton 0.876 0.866 0.876 0.874 0.866 0.874
Sensitivity BRASS striatum 83.7 86.1 83.7 79.1 67.4 74.4
BRASS putamen 83.7 83.7 81.4 83.7 76.7 81.4
Southampton 90.7 76.7 67.4 65.1 67.4 60.5
Specificity BRASS striatum 85.3 82.4 79.4 85.3 91.2 88.2
BRASS putamen 82.4 85.3 79.4 85.3 91.2 88.2
Southampton 82.4 82.4 82.4 88.2 88.2 88.2
The table shows the results for data with and without using a phantom calibration for iterative reconstruction with attenuation and scatter/septal penetration
reconstruction (ACSC), iterative reconstruction with no corrections (IRNC) and filtered back projection reconstruction, again with no corrections (FBP). The best
performance measure for each quantification technique is in bold, while the weakest is shown in italics
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in the caudate nucleus resulting in a normal overall
measurement of striatal SBR.
Since there is a known age-related decline in tracer
uptake [6], age-stratified diagnostic performance was
assessed using sensitivity/specificity analysis (Table 2).
Using a calibration to derive system specific normal
ranges provided no significant benefit for BRASS striatal
or putamen SBRs. There was a trend for slightly lower
striatal BRASS sensitivities and higher numbers of false
negatives without calibration, but these were not sig-
nificant. Conversely, with the Southampton method of
deriving SBRs, calibration led to increased sensitivity, a
trend present in the FBP and IRNC reconstructions that
became significant for the ACSC data. The impact of
this is seen in the reduced false negative numbers with
calibration shown in Table 3. Specificity remained simi-
lar with or without calibration across all reconstructions
and software. Knowing that the true negative rate is
similar across strategies is helpful given that specificity is
very important in the interpretation of this test and
arguably more important than sensitivity given this test
is not used as a screening tool in clinical use.
To understand the differences caused by calibration,
we must try to understand what this system character-
isation is achieving. The primary loss in signal from this
type of imaging is through partial volume effects. Using
the BRASS method of quantification where tight VOIs
are particularly susceptible to partial volume effects, the
primary influence of the calibration is to correct for
these effects, as can be seen in the pre- and post-
calibration normal ranges with this method (Figs. 1 and
2, respectively). Changes in striatal size are modest
across patients and indeed the normal subjects [14], at
least when compared to system spatial resolution [15].
Fig. 1 Calibrated normal ranges with follow-up data. Age-dependent ‘normal’ ranges of different calibrated quantitative SBRs measures with
various reconstructions. The dashed line shows the linear fit of the normal data, with solid lines representing the upper and lower level normal
range given by 95% confidence levels of the mean. Coloured dots represent patients suffering (red) and not suffering (green) from a syndrome
characterised by dopaminergic degeneration based on 3-year follow-up
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Given that the spatial resolution of most modern SPECT
systems is relatively similar with clinical radius of
rotations and typical reconstruction filters, the partial
volume effects for individual subjects will remain rela-
tively consistent. As a consequence, the calibration has
little effect on diagnostic performance of BRASS quanti-
fication. A small reduction in performance is found with
non-calibrated striatal SBR measures which is likely
caused by the partial volume effects of the smaller caud-
ate nuclei when it is included in the VOI. This is indeed
Table 3 The number of false positive and false negatives recorded for the different quantification methods, reconstruction
techniques and calibration strategies
Calibrated Non-calibrated
ACSC IRNC FBP ACSC IRNC FBP
False positives (34 normal subjects) BRASS striatum 5 6 7 5 3 4
BRASS putamen 6 5 7 5 3 4
Southampton 6 6 6 4 4 4
False negatives (43 abnormal subjects) BRASS striatum 7 6 7 9 14 11
BRASS putamen 7 7 8 7 10 8
Southampton 4 10 14 14 14 17
Fig. 2 Non-calibrated normal ranges with follow-up data. Age-dependent normal ranges of different non-calibrated quantitative measures with
various reconstructions. The dashed line shows the linear fit of the normal data, with solid lines representing the upper and lower level normal
range given by 95% confidence levels of the mean. Coloured dots represent patients suffering (red) and not suffering (green) from a syndrome
characterised by dopaminergic degeneration based on 3-year follow-up. Note the different y-axis ranges
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what happens on the left side of the brain in the study
shown in Fig. 4. Conversely with the Southampton
method of quantification, partial volume factors are
already accounted for, which can be seen by the much
smaller differences in calibrated and non-calibrated values
(Figs. 1 and 2). The calibration for the Southampton
method is therefore primarily correcting for other scanner
effects such as septal penetration from intra-brain and
extra-brain activity (i.e. from salivary glands and distant
organs), which can be more variable across scanner types
(Tossici-Bolt in submission). As a result, calibration for
this form of quantification becomes more important.
The use of different reconstructions has little effect on
the diagnostic performance of the BRASS quantification.
We might expect performance to be equalised with cali-
bration; however, the delivery of similar performance
across reconstructions using non-calibrated data does at
first seems surprising. We would expect that the attenu-
ation of I-123 gamma photons would be relatively
consistent across subjects and also that the scatter envir-
onment would be similar too. Septal penetration, which
we hope to be reduced using scatter correction, does
differ across subjects scanned on different scanners
(Tossici-Bolt in submission) but the results here suggest
that this is not a major factor with BRASS quantifica-
tion. Conversely, with the Southampton method, there
are again significant differences in sensitivity between
ACSC and IRNC reconstructions and ACSC and FBP
reconstructions using calibrated data. Specificity remains
unchanged. Once more, with the partial volume factors
removed using this quantification method, the correc-
tions for attenuation and scatter become more relevant.
With non-calibrated data, any gain in diagnostic per-
formance using corrections is lost, and differences
between reconstructions no longer seen.
We can see changes in quantitative diagnosis by focus-
sing on borderline cases. Figure 5 shows a clinically
normal follow-up subject whose diagnosis changes based
on the reconstruction used. When reconstructed using
FBP with calibration, this study is found to be abnormal,
while for most other reconstructions with or without
calibration, the study is quantitatively normal. Visually,
this study looks normal, although a mild reduction in
DAT binding is seen in the left posterior putamen and
possibly on the right posterior putamen as seen in the
ACSC reconstruction. Figure 3 shows that clinically nor-
mal cases disagree quantitatively most often with
calibrated filtered back projection reconstruction. Com-
pared to FBP, the iterative reconstruction suffers two
disadvantages: its spatially varying convergence rates and
its non-negativity constraint [16]. The non-negativity
constraint is likely to elevate count density in the
presence of low count densities, while the convergence
rates of iterative reconstruction are likely to lead to
Fig. 3 Discordance quantitative diagnoses. Cases with discordant quantitative diagnoses. Each row is grouped into cases with a clinically normal
and abnormal diagnosis. For a specific quantification, reconstruction and calibration strategy, quantitatively normal diagnoses are shown in green,
while an abnormal quantitative diagnosis in shown in red
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underestimations of count densities since incomplete
convergence is the norm in nuclear medicine imaging.
Both these factors would reduce SBRs potentially
making a normal study abnormal. However, in this in-
stance, the opposite effect is seen with FBP recon-
struction leading to an abnormal outcome while other
reconstructions give a normal outcome. In Fig. 1, it
can be seen that FBP produces slightly and indeed
significantly (Tossici-Bolt in submission) higher values
of striatal SBRs in the normal range compared to
IRNC, which means for this individual borderline
case, the increase in value is not as great as the aver-
age for the normal range. As a consequence, this
small shift in quantitative value has led to a large
shift in diagnosis from normal to abnormal, remind-
ing us that the quantitative assessment of borderline
cases either below or above the ‘normality line’ should
be treated with caution if these values are to guide
clinical interpretation.
Comparing the diagnostic performance of the quantifi-
cation methods, the Southampton method with ACSC
reconstructed data and calibration has a slightly higher
sensitivity than all other methods. This is highlighted in
Fig. 3, where two clinically abnormal cases that were
only classified as quantitatively abnormal using this
methodology, although statistically this method wasn’t
significantly better than many of the alternative tech-
niques. There are however some significant differences
in performance. Calibrated striatal BRASS quantification
with FBP reconstruction has a higher sensitivity than the
Southampton method because of the reduced perform-
ance of the FBP method with this form of quantification
as described above. In terms of non-calibrated data, the
poor performance of the Southampton method under
these conditions is reflected in poorer sensitivity than
putamen BRASS measures with both ACSC and FBP
reconstructions. An example of discordance from quan-
tification method is given in the clinically abnormal
follow-up studies shown in Fig. 6. In Fig. 6a, this study
Fig. 4 Divergent quantitative diagnosis based on calibration. Two
consecutive slices from a study of a 46-year-old female patient with
a 3-year follow-up diagnosis of a dopaminergic degenerative
disorder (Parkinson’s disease), which has a divergent quantitative
diagnosis based on the use of calibration. Without calibration,
the study was frequently found to be normal, while with
calibration the study was mostly abnormal
Fig. 5 Divergent quantitative diagnosis based on reconstruction.
Two consecutive slices from a study of a 29-year-old female patient
deemed not to have a degenerative dopaminergic syndrome on
follow-up, with divergent quantitative diagnosis depending on the
reconstruction used. Using a FBP reconstruction with calibration,
quantification found the study to be abnormal. Using other
reconstructions, the scan was rated as normal
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with visually balanced loss, clinically rated as abnormal,
is found to be abnormal quantitatively using all BRASS
measures and normal using almost all Southampton
measures. While the Southampton method’s large VOI
approach is helpful to help account for partial volume
losses, it can create problems in the small number of
patients with dilated ventricles, as shown in this Figure.
If the proportion of ventricle in the striatal and back-
ground areas is balanced, then quantification is not
affected. However, if there is an imbalance of ventricular
volumes in these regions, the SBR can be over- or
under-expressed. Conversely, in some instances, the
larger background region of interest used in the
Southampton method can add benefit by reducing noise
and therefore uncertainty in the measurement of non-
specific uptake [17]. In Fig. 6b, we see an incorrect
quantitative diagnosis using BRASS methods, while the
Southampton method concords with the follow-up clin-
ical diagnosis. Uptake in the caudate nuclei looks good
in this study, which explains the normal interpretation
based on striatal SBRs, while the anterior putamen still
shows good DAT binding and the posterior putamen
poorer binding. Overall, the anterior putamen dominates
the quantitative uptake figure, even though there is a
gradient of reduced uptake as we move to the posteriorly
that could be indicative of an abnormal scan. If the
BRASS method split the putamen uptake into smaller
anterior and posterior uptake figures, the posterior puta-
men may well have indicated an abnormal scan. In this
case, the complete striatal DAT binding figure is below
normal limits so that Southampton method gives the
interpretation of an abnormal scan, which corresponds
to the clinical diagnosis.
This study has focussed on the use of a normal data-
base in a clinical environment; however, there is growing
popularity of [123I]FP-CIT SPECT imaging in therapeutic
research both as a tool to determine entry to a study
and also to follow dopamine transporter availability
longitudinally through a treatment cycle. For entry to a
therapeutic trial, the requirements are similar to what is
required for a clinical diagnosis of Parkinson’s disease or
Lewy body dementia, although for borderline normal/
abnormal cases the implication of an incorrect diagnosis
may be different. For longitudinal imaging within a trial or
indeed for clinical follow-up, the focus is elsewhere, with
more emphasis on repeatability and the sensitivity to
detect change. It is not clear whether calibration would be
better in this instance. In an ideal scenario, longitudinal
imaging would be performed on the same scanner, but
this is not always possible. Unfortunately, the influence of
calibration, reconstruction and quantification method for
longitudinal imaging was not addressed in this project but
would be an interesting area of further study.
A potential limitation of this study is that follow-up
working diagnosis may be influenced by the result of
[123I]FP-CIT SPECT imaging. While initially the result
of this imaging study will clearly influence working
diagnosis, a working diagnosis at 3 years’ follow-up was
chosen so that any advance in disease would give a
clearer patient diagnosis less influenced by imaging
results. Another possible limitation is that for an im-
aging study that is compromised by the limited spatial
resolution of SPECT systems, we have not considered
Fig. 6 Divergent quantitative diagnosis based on method of
quantification. Patient studies with divergent quantitative diagnosis
based on the quantification method used. a Two consecutive slices
from a study of a 73-year-old male patient with a working diagnosis
of a dopaminergic degenerative disorder (Lewy body dementia) are
found to be abnormal using all BRASS quantification and rated
normal in all but the calibrated ACSC reconstruction using Southampton
quantification. b A clinically abnormal study of a 65-year-old
female patient with a 3-year follow-up diagnosis of a dopaminergic
degenerative disorder (multiple system atrophy) which was normal
using BRASS quantification with the exception of striatal and
putaminal binding ratios using a calibrated FBP approach (and
putamen non-calibrated) and rated abnormal with the Southampton
method of quantification. c The different assessment regions used. On
the left is one slice of several highlighting tight BRASS striatal regions
of interest over the caudate and putamen in addition to the occipital
lobe reference region. Right, the Southampton method is applied to
summed striatal slices with large VOIs to account for partial volume
effects with the reference region encompassing all other brain pixels
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the use of resolution modelling techniques in the image
reconstruction comparison. The reason for this is two-
fold. Firstly, our intention was to move away from com-
plex reconstruction algorithms to those more widely
available in the community, and resolution modelling
techniques are not standard on most SPECT installa-
tions. The second reason for not assessing resolution
modelling techniques was because of the known over-
shoot artefacts arising from this method which can
provide difficulties in quantitative imaging [18].
The values of sensitivity and specificity given in this
paper are lower than that normally reported for [123I]FP-
CIT SPECT [3]. This is a likely reflection of the cohort of
patients included in this study that were mixed in nature,
including typical and atypical parkinsonian syndromes,
and patients with Lewy body dementia. An additional
factor was that many of the referrals were from a national
movement disorder centre and may therefore constitute a
more complex mix of patients than that seen in typical
imaging centres.
Conclusions
In conclusion, in this relatively small patient cohort of
77 subjects, this study has shown that although the
diagnostic ability BRASS methods of quantification are
unaffected by reconstruction and calibration strategy,
the Southampton method, which offers greater accuracy
by accounting for the dominating issue of partial volume
effects, is affected by the choice of both reconstruction
and calibration. The choice of quantification method
used depends on user requirements. In terms of diag-
nostic capability, the performance of BRASS quantifica-
tion is found to be equal to the Southampton method in
this cohort and offers the benefit of robustness against
reconstruction or calibration choices. If, however, cali-
bration is performed and the Southampton method is
used with ACSC reconstruction, not only is diagnostic
ability slightly improved but also the accuracy of uptake
in SBR measured across the striata becomes a more
accurate reflection of the true value.
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